Skip to main content
. 2022 Feb 17;12(2):e054826. doi: 10.1136/bmjopen-2021-054826

Table 5.

Primary outcome subgroup 2

Non-operative treatment, n Direct appendectomy, n Absolute difference in proportions Unadjusted OR Propensity score adjusted absolute difference P value Propensity score adjusted OR P value
Complications after 3 months, n (%) N (% of total) N (% of total) Absolute difference (95% CI) OR (95% CI) Absolute difference (95% CI) p=0.XX O (95% CI) p=0.XX
Complication severity 
 Clavien-Dindo I N (% of total) N (% of total) Absolute Difference
(95% CI)
OR (95% CI) AbsoluteDifference
(95% CI)
p=0.XX OR (95% CI) p=0.XX
 Clavien-Dindo II N (% of total) N (% of total) Absolute Difference
(95% CI)
OR (95% CI) Absolute Difference
(95% CI)
p=0.XX OR (95% CI) p=0.XX
 Clavien-Dindo III N (% of total) N (% of total) Absolute Difference
(95% CI)
OR (95% CI) Absolute Difference
(95% CI)
p=0.XX OR (95% CI) p=0.XX
 Clavien-Dindo IV N (% of total) N (% of total) Absolute Difference
(95% CI)
OR (95% CI) Absolute Difference
(95% CI)
p=0.XX OR (95% CI) p=0.XX

*This column presents the pooled/combined results of the five propensity score strata.

†A similar table will be created for the subgroup analysis of patients with perioperative and histopathologically confirmed complex appendicitis wit abscess and/or mass formation